QTRX.NASDAQQuanterix CORP

Form 4: Quanterix CEO and Director Masoud Toloue Boosts Stake with Significant Stock Purchase

Sentiment:

Insider Transaction Report


Quanterix Corp's President and CEO, Masoud Toloue, has acquired 45,900 shares of common stock, signaling strong insider confidence in the company.

Better than expectedThe purchase of shares by the President and CEO indicates strong insider confidence in the company's valuation and future performance, which is generally viewed as a positive signal by the market.

Summary

  • Masoud Toloue, President & CEO and Director of Quanterix Corp (QTRX), purchased 45,900 shares of common stock.
  • The transaction occurred on June 9, 2025, at a weighted average price of $5.4188 per share.
  • Following this acquisition, Mr. Toloue directly beneficially owns a total of 518,922 shares of Quanterix common stock.
  • The total beneficial ownership includes 245,501 restricted stock units.

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to a significant insider purchase by the company's President and CEO, signaling strong confidence in the company's prospects and potentially undervalued stock.

Positives

  • The President and CEO, Masoud Toloue, increased his direct ownership in Quanterix Corp by purchasing 45,900 shares, indicating strong confidence in the company's future prospects.
  • Insider buying by a top executive and director often signals a belief that the stock is undervalued or that significant positive developments are anticipated.

Stakeholder Impact

  • Shareholders may view this insider purchase as a positive indicator of future stock performance and management's belief in the company's value.

Key Dates

DateDescription
06/08/2021Date of Power of Attorney granted by Masoud Toloue for SEC filings.
06/09/2025Date of the common stock acquisition by Masoud Toloue.
06/10/2025Date the Form 4 was filed with the SEC.

Recommendation

buy

Keywords

Quanterix Corp, QTRX, Masoud Toloue, Insider Trading, Stock Purchase, CEO, Director, SEC Form 4, Biotechnology, Life Sciences, Diagnostic Tools

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.